{"title":"基因多态性与成人非典型抑郁症的关系:系统回顾","authors":"Aysylu Galiautdinova, Iuliia Dolgopolova, Daria Troshina, Dmitry Petelin, Beatrice Volel","doi":"10.36131/cnfioritieditore20240503","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Atypical depression (AD) is a clinical subtype of depression characterised by mood reactivity and at least two of the following features: significant weight gain/increased appetite, hypersomnia, leaden paralysis, and/or interpersonal rejection sensitivity. The role of genetics in the development of depression remains a considerable level of interest among individuals. Due to the large number of breakthrough studies in genetics, there is currently a wealth of heterogeneous data on the existence of genetic markers for depression, including AD. However, it appears that there is a gap in the literature, as we were unable to identify any systematic reviews or meta-analyses that comprehensively describe these data. Therefore, our research aims to provide high-quality, solid evidence for further studies in this area.</p><p><strong>Method: </strong>Electronic bibliographic databases (Scopus, MEDLINE) were systematically searched from inception to September 2023. We searched for any specific genetic markers that could be retrieved associated with AD. The quality of studies has been assessed by means of the Q-genie tool.</p><p><strong>Results: </strong>Nine studies meeting the inclusion criteria were selected, which appeared to link genetic polymorphisms to atypical depression. Four studies examined genetic polymorphisms associated with the serotonin transporter gene (5-HTT), three studies examined genetic polymorphisms associated with endocrine regulation, two studies considered genetic polymorphisms associated with immune and/or cellular regulation, specifically the melanin-concentrating hormone receptor 2 (MCHR2), mineralocorticoid receptor (MR), and fat mass and obesity-associated protein (FTO) genes involved in the regulation of energy balance.</p><p><strong>Conclusions: </strong>The extracted data confirm that the atypical type of major depressive disorder is heritable to a certain extent. Individual risk markers for developing this type of depression may be identified in the future.</p>","PeriodicalId":46700,"journal":{"name":"Clinical Neuropsychiatry","volume":"21 5","pages":"376-384"},"PeriodicalIF":2.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11555661/pdf/","citationCount":"0","resultStr":"{\"title\":\"The Association of Genetic Polymorphisms and Atypical Depression in Adults: A Systematic Review.\",\"authors\":\"Aysylu Galiautdinova, Iuliia Dolgopolova, Daria Troshina, Dmitry Petelin, Beatrice Volel\",\"doi\":\"10.36131/cnfioritieditore20240503\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Atypical depression (AD) is a clinical subtype of depression characterised by mood reactivity and at least two of the following features: significant weight gain/increased appetite, hypersomnia, leaden paralysis, and/or interpersonal rejection sensitivity. The role of genetics in the development of depression remains a considerable level of interest among individuals. Due to the large number of breakthrough studies in genetics, there is currently a wealth of heterogeneous data on the existence of genetic markers for depression, including AD. However, it appears that there is a gap in the literature, as we were unable to identify any systematic reviews or meta-analyses that comprehensively describe these data. Therefore, our research aims to provide high-quality, solid evidence for further studies in this area.</p><p><strong>Method: </strong>Electronic bibliographic databases (Scopus, MEDLINE) were systematically searched from inception to September 2023. We searched for any specific genetic markers that could be retrieved associated with AD. The quality of studies has been assessed by means of the Q-genie tool.</p><p><strong>Results: </strong>Nine studies meeting the inclusion criteria were selected, which appeared to link genetic polymorphisms to atypical depression. Four studies examined genetic polymorphisms associated with the serotonin transporter gene (5-HTT), three studies examined genetic polymorphisms associated with endocrine regulation, two studies considered genetic polymorphisms associated with immune and/or cellular regulation, specifically the melanin-concentrating hormone receptor 2 (MCHR2), mineralocorticoid receptor (MR), and fat mass and obesity-associated protein (FTO) genes involved in the regulation of energy balance.</p><p><strong>Conclusions: </strong>The extracted data confirm that the atypical type of major depressive disorder is heritable to a certain extent. Individual risk markers for developing this type of depression may be identified in the future.</p>\",\"PeriodicalId\":46700,\"journal\":{\"name\":\"Clinical Neuropsychiatry\",\"volume\":\"21 5\",\"pages\":\"376-384\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11555661/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Neuropsychiatry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36131/cnfioritieditore20240503\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Neuropsychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36131/cnfioritieditore20240503","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的:非典型抑郁症(AD)是抑郁症的一种临床亚型,其特征是情绪反应性和至少以下两个特征:体重明显增加/食欲增加、嗜睡、铅中毒和/或人际排斥敏感。遗传在抑郁症发病过程中的作用仍然是人们相当关注的问题。由于遗传学方面的大量突破性研究,目前关于抑郁症(包括注意力缺失症)的遗传标记存在大量不同的数据。然而,由于我们无法找到全面描述这些数据的系统综述或荟萃分析,因此文献中似乎存在空白。因此,我们的研究旨在为这一领域的进一步研究提供高质量的可靠证据:系统检索了从开始到 2023 年 9 月的电子文献数据库(Scopus、MEDLINE)。我们搜索了与 AD 相关的任何特定遗传标记。研究质量通过 Q-genie 工具进行评估:符合纳入标准的九项研究被选中,这些研究似乎将基因多态性与非典型性抑郁症联系在一起。四项研究考察了与血清素转运体基因(5-HTT)相关的基因多态性,三项研究考察了与内分泌调节相关的基因多态性,两项研究考虑了与免疫和/或细胞调节相关的基因多态性,特别是黑色素浓缩激素受体2(MCHR2)、矿物质皮质激素受体(MR)以及参与能量平衡调节的脂肪量和肥胖相关蛋白(FTO)基因:提取的数据证实,非典型重度抑郁症在一定程度上具有遗传性。结论:提取的数据证实,非典型型重度抑郁症在一定程度上具有遗传性,未来可能会发现罹患该类型抑郁症的个体风险标记。
The Association of Genetic Polymorphisms and Atypical Depression in Adults: A Systematic Review.
Objective: Atypical depression (AD) is a clinical subtype of depression characterised by mood reactivity and at least two of the following features: significant weight gain/increased appetite, hypersomnia, leaden paralysis, and/or interpersonal rejection sensitivity. The role of genetics in the development of depression remains a considerable level of interest among individuals. Due to the large number of breakthrough studies in genetics, there is currently a wealth of heterogeneous data on the existence of genetic markers for depression, including AD. However, it appears that there is a gap in the literature, as we were unable to identify any systematic reviews or meta-analyses that comprehensively describe these data. Therefore, our research aims to provide high-quality, solid evidence for further studies in this area.
Method: Electronic bibliographic databases (Scopus, MEDLINE) were systematically searched from inception to September 2023. We searched for any specific genetic markers that could be retrieved associated with AD. The quality of studies has been assessed by means of the Q-genie tool.
Results: Nine studies meeting the inclusion criteria were selected, which appeared to link genetic polymorphisms to atypical depression. Four studies examined genetic polymorphisms associated with the serotonin transporter gene (5-HTT), three studies examined genetic polymorphisms associated with endocrine regulation, two studies considered genetic polymorphisms associated with immune and/or cellular regulation, specifically the melanin-concentrating hormone receptor 2 (MCHR2), mineralocorticoid receptor (MR), and fat mass and obesity-associated protein (FTO) genes involved in the regulation of energy balance.
Conclusions: The extracted data confirm that the atypical type of major depressive disorder is heritable to a certain extent. Individual risk markers for developing this type of depression may be identified in the future.